Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Puretech Health Plc ADR (NQ: PRTC ) 22.27 UNCHANGED Streaming Delayed Price Updated: 11:08 AM EDT, Jul 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Puretech Health Plc ADR < Previous 1 2 3 4 5 6 7 Next > PureTech Founded Entity Gelesis Announces its Proprietary Superabsorbent Hydrogel Induced Beneficial Changes to the Gut Microbiota and Expanded Akkermansia, a Bacterial Species Associated with Gut Health and Weight Loss, in New Study April 29, 2022 From PureTech Health plc Via Business Wire Earnings Scheduled For April 26, 2022 April 26, 2022 Companies Reporting Before The Bell • First American Financial (NYSE:FAF) is estimated to report quarterly loss at $0.09 per share on revenue of $46.41 million. Via Benzinga PureTech Announces Annual Results for Year Ended December 31, 2021 April 26, 2022 From PureTech Via Business Wire PureTech Health Earnings Conference Call Is Coming Up, Here's What You Need To Know April 14, 2022 PureTech Health (NASDAQ:PRTC) will host a conference call at 02:00 AM ET on April 26, 2022, to discuss FY 2021 earnings results. How to Attend PureTech Health (PRTC) Conference Call Follow this link to... Via Benzinga PureTech Founded Entity Vedanta Biosciences Publishes Phase 1a/1b Results for Lead Program VE303 in Cell Host & Microbe and Highlights Planned Presentations of Phase 2 VE303 Results April 13, 2022 From PureTech Health plc Via Business Wire PureTech Founded Entity Akili Announces American Journal of Psychiatry Publication of Data Demonstrating its Digital Therapeutic AKL-T03 Improves Cognitive Impairments in Adults w/ Major Depressive Disorder When Combined w/ Antidepressant Medication April 12, 2022 From PureTech Health plc Via Business Wire PureTech Announces Publication of Research from Collaborators Demonstrating PureTech’s Glyph™ Platform Enhances Oral Absorption of Buprenorphine (a Clinically-Validated Opioid Replacement Therapy) April 12, 2022 From PureTech Health plc Via Business Wire PureTech Health: Notice of Results April 07, 2022 From PureTech Health Via Business Wire Drug makers, Scientists Working For Long COVID Treatments: Reuters March 25, 2022 Researchers and drugmakers, including those who have launched antiviral pills and monoclonal antibodies for COVID-19, are having early discussions about targeting Long COVID, Via Benzinga PureTech Appoints Sharon Barber-Lui to Board of Directors & Audit Committee March 24, 2022 From PureTech Health plc Via Business Wire PureTech Founded Entity Akili Appoints Game Industry Veteran Behind Bejeweled, Plants vs. Zombies as Chief Product Officer March 17, 2022 From PureTech Health plc Via Business Wire PureTech Founded Entity Gelesis® Releases Preliminary National Launch Results for Plenity®: Record-Breaking Levels of Prescriptions and Online Traffic March 16, 2022 From PureTech Health plc Via Business Wire Stocks That Hit 52-Week Lows On Wednesday March 09, 2022 During Wednesday's session, 35 companies made new 52-week lows. 52-Week High And Low Highlights: The company with the largest market cap to set a new 52-week low was... Via Benzinga Stocks That Hit 52-Week Lows On Friday February 18, 2022 On Friday, 313 companies hit new 52-week lows. Things to Consider About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week... Via Benzinga PureTech Founded Entity Akili Announces PLOS ONE Publication of Clinical Study Results and EEG Data Showing Akili Digital Therapeutic EndeavorRx® Activates Systems in Brain Key to Attentional Functioning February 17, 2022 From PureTech Health plc Via Business Wire PureTech Founded Entity Akili Interactive Announces Filing of Registration Statement on S-4 in Connection with its Proposed Business Combination with Social Capital Suvretta Holdings Corp. I February 15, 2022 From PureTech Health Via Business Wire PureTech to Present at the SVB Leerink 11th Annual Global Healthcare Conference February 10, 2022 From PureTech Health Via Business Wire PureTech Founded Entity Gelesis to Launch Plenity® National Media Campaign That Challenges Restrictive Dieting Norms January 31, 2022 From PureTech Health plc Via Business Wire PureTech Founded Entity Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I January 26, 2022 From PureTech Health plc Via Business Wire 12 Health Care Stocks Moving In Friday's Intraday Session January 21, 2022 Gainers Biophytis (NASDAQ:BPTS) shares rose 12.3% to $5.28 during Friday's regular session. The market value of their outstanding shares is at $68.0 million. Intra-... Via Benzinga Gelesis, Maker Of Weight Loss Pill, Concludes SPAC Deal; Trading Kickstarts Today January 14, 2022 PureTech Health plc (NASDAQ: PRTC) founded entity Gelesis Inc, maker of weight management aid, has completed its business combination with Capstar Special... Via Benzinga PureTech Founded Entity Gelesis, the Maker of Plenity® for Weight Management, Will Debut as a Publicly Traded Company Following the Closing of its Business Combination with Capstar January 14, 2022 From PureTech Health plc Via Business Wire PureTech to Present at 40th Annual J.P. Morgan Healthcare Conference January 07, 2022 From PureTech Health plc Via Business Wire PureTech’s LYT-100 (Deupirfenidone) Achieves 50% Reduction in Healthy Older Adults Experiencing GI-Related Adverse Events Compared to Pirfenidone January 06, 2022 From PureTech Health plc Via Business Wire PureTech Founded Entity Gelesis Appoints Inogen Co-Founder and Former CFO Ali Bauerlein to Board of Directors and Audit Committee January 05, 2022 From PureTech Health plc Via Business Wire PureTech Provides End of Year Report on Key Progress Across Wholly Owned Programs and Founded Entities December 16, 2021 From PureTech Health Via Business Wire PureTech Presents Preclinical Proof-of-Concept Data for LYT-300 (Oral Allopregnanolone) as Potential Treatment for Neurological and Neuropsychological Conditions December 08, 2021 From PureTech Health plc Via Business Wire PureTech Advances Wholly-Owned Candidate LYT-300 (Oral Allopregnanolone) into Clinical Study for Potential Treatment of Neurological and Neuropsychological Conditions December 07, 2021 From PureTech Health plc Via Business Wire 12 Health Care Stocks Moving In Thursday's Intraday Session December 02, 2021 Gainers Biofrontera (NASDAQ:BFRI) shares ... Via Benzinga PureTech Founded Entity Gelesis Announces FDA-Cleared Weight Management Approach, Plenity®, Now Broadly Available and Leading Nutrition Authority Joy Bauer, MS, RDN, CDN, Joins as Chief Nutrition Officer December 01, 2021 From PureTech Health plc Via Business Wire < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.